Attached files

file filename
10-K - FORM 10-K - CYPRESS BIOSCIENCE INCa55504e10vk.htm
EX-32 - EX-32 - CYPRESS BIOSCIENCE INCa55504exv32.htm
EX-31.1 - EX-31.1 - CYPRESS BIOSCIENCE INCa55504exv31w1.htm
EX-31.2 - EX-31.2 - CYPRESS BIOSCIENCE INCa55504exv31w2.htm
EX-21.1 - EX-21.1 - CYPRESS BIOSCIENCE INCa55504exv21w1.htm
EX-10.21 - EX-10.21 - CYPRESS BIOSCIENCE INCa55504exv10w21.htm
EX-10.19 - EX-10.19 - CYPRESS BIOSCIENCE INCa55504exv10w19.htm
EX-10.18 - EX-10.18 - CYPRESS BIOSCIENCE INCa55504exv10w18.htm
EX-10.20 - EX-10.20 - CYPRESS BIOSCIENCE INCa55504exv10w20.htm
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements (Form S-3 Nos. 333-01071, 333-04323, 333-15483, 333-39759, 333-66269, 333-87038, 333-104954, 333-110158 and 333-124779, and Form S-8 Nos. 333-06771, 333-06765, 333-19465, 333-59164, 333-88544, 333-116662, 333-147258 and 333-161264) of Cypress Bioscience, Inc. and in the related Prospectus of our reports dated March 30, 2010 with respect to the consolidated financial statements of Cypress Bioscience, Inc., and the effectiveness of internal control over financial reporting of Cypress Bioscience, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2009.
/s/ Ernst & Young LLP
San Diego, California
March 30, 2010